Thursday, 26 January 2023

Hope for more than 150,000 migraine sufferers as NHS approves new wonder drug

Hope for more than 150,000 migraine sufferers as NHS approves new wonder drug A new drug is set to transform the lives of thousands of migraine sufferers after it was approved for use on the NHS.

The National Institute for Health and Care Excellence (NICE) is recommending eptinezumab for around 164,000 adults where at least three previous preventive treatments have failed.

The drug, given as an intravenous infusion every 12 weeks in hospital, has been found to reduce both frequency and severity of migraine attacks. The Daily Mail

See also:
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)